Bad news about growth hormone treatment in the intensive care unit: Need for some clarification

Current Opinion in Anaesthesiology

Volumn 14, Issue 2, 2001, Pages 127-129

  Van den Berghe, G ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DOUBLE BLIND PROCEDURE; EDITORIAL; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; HYPERMETABOLISM; HYPOGONADISM; HYPOPITUITARISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHYROIDISM; INSULIN RESISTANCE; INTENSIVE CARE; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SEPTIC SHOCK; WASTING SYNDROME;

EID: 0035081276     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200104000-00001     Document Type: Editorial

References (21)

1. Protein metabolism and the use of growth hormone and insulin-like growth factor-I in the critically ill patient
2. Increased mortality associated with growth hormone treatment in critically ill adults
3. Acute and prolonged critical illness as different neuroendocrine paradigms
4. Growth hormone secretion in critical illness: Effect of dopamine
5. Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: Demonstration of reduced expression after elective surgery
6. Levels of GH-binding activity, IGFBP-1, insulin, blood glucose and cortisol in intensive care patients
7. Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease
8. A multicenter study of the dose response effect of human recombinant growth hormone (rhGH) on cumulative nitrogen balance in patients after major abdominal surgery
9. Improved cumulated nitrogen balance after administration of recombinant human growth hormone in patients undergoing gastrointestinal surgery
10. The somatotropic axis in critical illness: Effect of continuous GHRH and GHRP-2 infusion
11. Neuroendocrinology of prolonged critical illness: Effect of exogenous thyrotropin-releasing hormone infusion and its combination with growth hormone-secretagogues
12. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness
13. A paradoxical gender dissociation within the growth hormone/IGF-I axis during prolonged critical illness
14. Growth hormone as a rescue treatment after heart-lung or double lung transplantation
15. Hypercalcemia associated with the use of human growth hormone in an adult surgical intensive care unit
16. Thyrotropin and prolactin release in prolonged critical illness: Dynamics of spontaneous secretion and effects of growth hormone secretagogues
17. Adrenal insufficiency in the surgical intensive care unit patient
18. The role of vasopressin in the impaired water excretion of myxedema
19. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: Evidence for growth hormone modulation of extrarenal 11b-hydoxysteroid dehydrogenase activity
20. Hemodynamic changes in acute adrenal insufficiency
21. Novel insights into the neuroendocrinology of critical illness